Atrium Therapeutics, Inc. (RNA) Ownership - Who Owns Atrium Therapeutics, Inc.?

9 Followers

Atrium Therapeutics, Inc. (RNA) Ownership Overview

2.24% Insiders

42.62% Other Institutional Investors

9.42% ETFs

45.72% Public Companies and

Individual Investors

The ownership structure of Atrium Therapeutics, Inc. (RNA) stock is a mix of institutional, retail, and individual investors. , 2.24% is owned by Insiders, and 45.72% is owned by Public Companies and Individual Investors.

The ownership structure of Atrium Therapeutics, Inc. (RNA) stock is a mix of institutional, retail, and individual investors. Approximately 52.04% of the company’s stock is owned by Institutional Investors, 2.24% is owned by Insiders, and 45.72% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2026	Saba Capital Management	xxxxxxxxxxxxx	$529987
Mar 31, 2026	Fortress Investment Group Llc	xxxxxxxxxxxxx	$294581
Mar 31, 2026	Farallon Capital Management, L.l.c.	xxxxxxxxxxxxx	$4670943
Mar 31, 2026	Highbridge Capital Management Llc	xxxxxxxxxxxxx	$547983

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	951,629	Institution	5.56%	12,047,623
Peter Kolchinsky	864,102	Institution	5.05%	10,939,531
	422,310	Institution	2.47%	5,346,445
Andrew J.M. Spokes	349,360	Institution	2.04%	4,422,898
	131,361	Insider	0.77%	1,663,030
	78,904	Institution	0.46%	998,925
	76,963	Institution	0.45%	974,352
	73,097	Insider	0.43%	925,408
	52,657	Insider	0.31%	666,638
	46,660	Insider	0.27%	590,716

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	443,916	Institution	2.60%	5,770,908
iShares Russell 2000 ETF	283,085	Institution	1.65%	3,583,856
Vanguard Small-Cap ETF	168,392	Institution	0.98%	2,189,096
Vanguard Extended Market ETF	158,780	Institution	0.93%	2,064,140
iShares Russell 2000 Growth ETF	98,743	Institution	0.58%	1,250,086
Janus Henderson Small Cap Growth Alpha ETF	78,904	Institution	0.46%	998,925
Schwab U.S. Small-Cap ETF	67,649	Institution	0.40%	844,260
Vanguard Russell 2000 ETF	62,889	Institution	0.37%	817,557
Vanguard Small Cap Value ETF	54,968	Institution	0.32%	714,584
Vanguard Small-Cap Growth ETF	47,034	Institution	0.27%	611,442

FAQ

Who Owns Atrium Therapeutics, Inc. (RNA)?

According to the latest TipRanks data, approximately 42.62% of the company's stock is held by institutional investors, 2.24% is held by insiders, and 45.72% is held by retail investors.

What percentage of Atrium Therapeutics, Inc. (RNA) stock is held by institutional investors?

According to the latest TipRanks data, approximately 42.62% of Atrium Therapeutics, Inc. (RNA) stock is held by institutional investors.

What percentage of Atrium Therapeutics, Inc. (RNA) stock is held by retail investors?

According to the latest TipRanks data, approximately 45.72% of Atrium Therapeutics, Inc. (RNA) stock is held by retail investors.

Who owns the most shares of Atrium Therapeutics, Inc. (RNA)?

Vanguard owns the most shares of Atrium Therapeutics, Inc. (RNA).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.